Abiopharma

New Form 424B3 - US BANCORP \DE\ <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001918704-26-012754 <b>Size:</b> 88 KB

Saba Capital Management, L.P. 🔴 sold 216.3K shares of BlackRock ESG Capital Allocation Term Trust (ECAT) at $15.34 ($3.3M) Transaction Date: May 11, 2026 | Filing ID: 000171

📋 Grasso Alfred (Director) plans to sell 5K shares of NETSCOUT SYSTEMS INC (at $40.67 each, total $203K) Filed: May 12, 2026 | ID: 003507

📋 JOHANNESSEN JAN (Director) plans to sell 12K shares of Twist Bioscience Corp (at $56.12 each, total $673K) Filed: May 12, 2026 | ID: 003506

New Form SCHEDULE 13G/A - Perspective Therapeutics, Inc. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000895421-26-000172 <b>Size:</b> 8 KB

📋 Heller Bridgette P (Director) plans to sell 1K shares of DEXCOM INC (at $60.01 each, total $61K) Filed: May 12, 2026 | ID: 003505

New Form 424B3 - US BANCORP \DE\ <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001918704-26-012753 <b>Size:</b> 88 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interests of Director - Chan Wei Jie (Zeng Wei Jie)

📋 Palmer Duncan (Director) plans to sell 505 shares of OSHKOSH CORP (at $133.86 each, total $68K) Filed: May 12, 2026 | ID: 003504

📋 Jardine Bret T (Officer) plans to sell 682 shares of FIRST ADVANTAGE CORP (at $16.12 each, total $11K) Filed: May 12, 2026 | ID: 003503